I think the very next Q will show a massive jump in revenue that will make some sit up and take notice. The potential to become cash flow positive is also going to be evident. The market will sit up and rate the stock accordingly. I plan to hang around now until it does. Averaging down in the meantime may make this a perfect opportunity for all, and recharge our batteries. Did I say batteries. oops. shshhhh..
DCN - Clinical Study, page-21
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
